News & Updates

Catheter-directed thrombolysis trumps systemic anticoagulation for submassive pulmonary embolism
Catheter-directed thrombolysis trumps systemic anticoagulation for submassive pulmonary embolism
07 Jul 2022

Catheter-directed thrombolysis (CDT) is superior to systemic anticoagulation (SA) for the treatment of submassive pulmonary embolism (sPE), leading to better mortality rates without additional safety signals, a recent meta-analysis has found.

Catheter-directed thrombolysis trumps systemic anticoagulation for submassive pulmonary embolism
07 Jul 2022
Fatigue persists as lung function improves months after COVID-19 hospitalization
Fatigue persists as lung function improves months after COVID-19 hospitalization
28 Jun 2022 byStephen Padilla

COVID-19 patients remain on the recovery phase 6 months after hospital admission, with persistent fatigue but improving lung function and quality of life, according to a study.

Fatigue persists as lung function improves months after COVID-19 hospitalization
28 Jun 2022
Response analysis further establishes tezepelumab benefit in severe uncontrolled asthma
Response analysis further establishes tezepelumab benefit in severe uncontrolled asthma
27 Jun 2022 byRoshini Claire Anthony

Adolescents and adults with severe uncontrolled asthma while on inhaled corticosteroids (ICS) had greater responses to the human monoclonal antibody tezepelumab than placebo, according to prespecified exploratory results of the phase III NAVIGATOR trial.

Response analysis further establishes tezepelumab benefit in severe uncontrolled asthma
27 Jun 2022
COPD tied to earlier lung cancer diagnosis
COPD tied to earlier lung cancer diagnosis
27 Jun 2022 byAudrey Abella

Chronic obstructive pulmonary disease (COPD) is associated with an earlier diagnosis of lung cancer, according to a cross-sectional, real-world study.

COPD tied to earlier lung cancer diagnosis
27 Jun 2022
Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data
Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data
27 Jun 2022 byKanas Chan

Older adults have weaker antibody responses to two doses of COVID-19 vaccines [ie, mRNA-based BNT162b2 vaccine and inactivated CZ02 vaccine] vs younger individuals, but a booster dose mounts SARS-CoV-2 neutralization activities to a high level, according to data presented at AIM 2022.

Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data
27 Jun 2022